Sinha, P., Mostaghim, A., Bielick, C. G., McLaughlin, A., Hamer, D. H., Wetzler, L. M., . . . Sagar, M. (2020). Early administration of interleukin-6 inhibitors for patients with severe COVID-19 disease is associated with decreased intubation, reduced mortality, and increased discharge. Int J Infect Dis.
Styl ChicagoSinha, Pranay, et al. "Early Administration of Interleukin-6 Inhibitors for Patients With Severe COVID-19 Disease Is Associated With Decreased Intubation, Reduced Mortality, and Increased Discharge." Int J Infect Dis 2020.
Citace podle MLASinha, Pranay, et al. "Early Administration of Interleukin-6 Inhibitors for Patients With Severe COVID-19 Disease Is Associated With Decreased Intubation, Reduced Mortality, and Increased Discharge." Int J Infect Dis 2020.